Loading...
Thumbnail Image
Item

Scaling Digital Therapeutics for Substance Use Disorders: What the First Real Cost Study Reveals

Wong, Edwin S.
Dorsey, Caitlin N.
Beatty, Tara C.
Bobb, Jennifer F.
Stefanik-Guizlo, Kelsey
Key, Dustin L.
Ramaprasan, Arvind
Idu, Abisola E.
Fortney, John C.
Mogk, Jessica
... show 5 more
Other Titles
See at
Abstract

Digital therapeutics—evidence-based apps prescribed for substance use disorders (SUD)— deliver proven, convenient treatment that reduces substance use, supports recovery, and relieves strain on clinicians and emergency services. Yet real-world uptake lags, not from lack of effectiveness, but from implementation hurdles. A landmark study, “Economic Cost of Strategic Implementation Approaches to Increase Uptake of Digital Therapeutics for Substance Use Disorders in a Large Integrated Health System,” published in PLOS Digital Health, provides the first concrete numbers on scaling these tools. Over 50 months across 21 primary care sites in a large integrated health system, strategic implementation (including training, practice facilitation, health coaching, and operations) totaled $748,088—about $25,000 per clinic for basic rollout, up to $48,000 for the most intensive combinations.

Data Availibility
Data / Code Location
Table of Contents
Description
Article published in Chestnut Health Systems' newsletter, The Catalyst.
Series/Report No.
Sponsors
Rights/Terms
Citation
Identifier to cite or link to this item
Scopus Identifier
Embedded videos